#$%^&*AU2016247068A120161103.pdf#####ABSTRACT Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancer. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.